The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.

The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ.

Mostra altre versioni (1)

Lineage fate decisions underpin much of development as well as tissue homeostasis in the adult. A mechanistic paradigm for such decisions is the erythroid versus myeloid fate decision controlled by cross-antagonism between gata1 and pu.1 transcription factors. In this study, we have systematically t...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Monteiro, R, Pouget, C, Patient, R
Natura:	Journal article
Lingua:	English
Pubblicazione:	2011

Documenti analoghi

The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1γ
di: Monteiro, R, et al.
Pubblicazione: (2011)

Lineage marker synchrony in hematopoietic genealogies refutes the PU.1/GATA1 toggle switch paradigm
di: Michael K. Strasser, et al.
Pubblicazione: (2018-07-01)

The Roles of TIF1γ in Cancer
di: Chengpeng Yu, et al.
Pubblicazione: (2019-10-01)

Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios
di: Hoppe, P, et al.
Pubblicazione: (2016)

Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
di: Yorihisa Kotobuki, et al.
Pubblicazione: (2021-01-01)

GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription.
di: Nerlov, C, et al.
Pubblicazione: (2000)

Clinical characteristics of patients with anti-TIF1-γ antibodies
di: Anna Masiak, et al.
Pubblicazione: (2016-03-01)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
di: Daniel Gutierrez, MD, et al.
Pubblicazione: (2022-04-01)

Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1.
di: Liew, C, et al.
Pubblicazione: (2006)

PU.1 and Haematopoietic Cell Fate: Dosage Matters
di: Ka Sin Mak, et al.
Pubblicazione: (2011-01-01)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
di: Spyridon Megremis, et al.
Pubblicazione: (2021-03-01)

Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesis
di: Rossmann, Marlies P, et al.
Pubblicazione: (2021)

GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies.
di: Elsa P Amanatiadou, et al.
Pubblicazione: (2015-01-01)

Inferring structural properties of protein-DNA binding using high-throughput sequencing. The paradigm of GATA1, KLF1 and their complexes GATA1/FOG1 and GATA1/KLF1. Insights into the transcriptional regulation of the erythroid cell lineage.
di: Oikonomopoulos, S
Pubblicazione: (2014)

Amyopathic anti‐TIF1‐γ antibody‐positive dermatomyositis in a young man
di: Nicolas Kluger
Pubblicazione: (2024-07-01)

A Rare Case of Anti-TIF-1γ Antibody Positive Dermatomyositis in Adulthood
di: Upasana Agrawal MD, et al.
Pubblicazione: (2024-06-01)

First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
di: B. Palterer, et al.
Pubblicazione: (2017-08-01)

Dynamic regulation of Tgf-B signaling by Tif1γ: a computational approach.
di: Geoffroy Andrieux, et al.
Pubblicazione: (2012-01-01)

Correction: Inactivation of TIF1γ Cooperates with Kras to Induce Cystic Tumors of the Pancreas.
di: David F. Vincent, et al.
Pubblicazione: (2009-08-01)

Anti‐TIF‐1γ dermatomyositis: Erythematous eruption with weakness and normal creatine kinase
di: Lucy Mackie, et al.
Pubblicazione: (2024-06-01)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
di: Chih-Feng Wu, et al.
Pubblicazione: (2023-09-01)

Association of Mutation and Methylation in the Promoter Region of TIF1γ  with Non-small Cell Lung Cancer
di: Longqiang WANG, et al.
Pubblicazione: (2013-05-01)

Correction: Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
Pubblicazione: (2009-08-01)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
di: Natsuo Tomita, MD, PhD, et al.
Pubblicazione: (2021-07-01)

Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate.
di: Bakri, Y, et al.
Pubblicazione: (2005)

PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
di: Takuya Yashiro, et al.
Pubblicazione: (2015-01-01)

Lineage-specific combinatorial action of enhancers regulates mouse erythroid Gata1 expression.
di: Drissen, R, et al.
Pubblicazione: (2010)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
di: Ryosuke Imai, et al.
Pubblicazione: (2021-04-01)

PTEN regulates hematopoietic lineage plasticity via PU.1-dependent chromatin accessibility
di: Zihan Xu, et al.
Pubblicazione: (2023-08-01)

Association Between Anti‐TIF1‐γ Antibody and Triple‐Negative Breast Carcinoma in Dermatomyositis Patients: A Case Report
di: Fan Zhang, et al.
Pubblicazione: (2025-02-01)

A Case of Paraneoplastic Anti-TIF1-γ Antibody-Positive Dermatomyositis Presenting with Generalized Edema and Associated with Aortic Aneurysm
di: Raven Bennett, et al.
Pubblicazione: (2023-10-01)

Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice
di: Anaís Mariscal, et al.
Pubblicazione: (2021-02-01)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
di: Joanna E. Parkes, et al.
Pubblicazione: (2018-06-01)

The TIF1β-HP1 System Maintains Transcriptional Integrity of Hematopoietic Stem Cells
di: Satoru Miyagi, et al.
Pubblicazione: (2014-02-01)

PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
di: Xinhui Zhao, et al.
Pubblicazione: (2022-09-01)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
di: Jason Kieffer, MD, et al.
Pubblicazione: (2024-03-01)

Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
di: Gering, M, et al.
Pubblicazione: (2003)

Case Report: IVIG causing bilateral papilledema and increased intracranial hypertension in patients with anti-TIF-1γ antibody-positive JDM
di: Sarah Baluta, et al.
Pubblicazione: (2024-11-01)

A Case Report of Anti-TIF1-γAntibody-Positive Dermatomyositis Concomitant with Small Cell Neuroendocrine Carcinoma of the Urinary Bladder
di: Hiroyuki Hounoki, et al.
Pubblicazione: (2023-01-01)

Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
di: Lijuan Zhao, et al.
Pubblicazione: (2022-02-01)